ReportGem ReportGem 中文

TODAY'S MARKET INTELLIGENCE

IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?

Published: 2026-08-20 21:36:04Category: financeHeat: 36

English summary

XBI has risen nearly 80% over the past year but has experienced a much larger maximum drawdown over five years; IHE offers steadier returns and a higher dividend yield. The article compares risk-return profiles without explicit advice.

The English text is machine translated and may require verification against the Chinese version.

Browse today's intelligence